{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Research+blood+draw&page=34", "query": { "intervention": "Research blood draw", "page": 34 }, "page_size": 10 }, "pagination": { "page": 34, "page_size": 10, "total_count": 1005, "total_pages": 101, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Research+blood+draw&page=35&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Research+blood+draw&page=33&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-15T17:28:52.123Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02990078", "title": "Non-invasive Measurement of Cerebrovascular Reactivity After Traumatic Brain Injury", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "TBI" ], "interventions": [ { "name": "Sildenafil citrate", "type": "DRUG" }, { "name": "Functional Near Infared Spectroscopy", "type": "DEVICE" }, { "name": "Hypercapnia Challenge", "type": "OTHER" } ], "intervention_types": [ "DRUG", "DEVICE", "OTHER" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 26, "start_date": "2016-12", "completion_date": "2022-09-30", "has_results": false, "last_update_posted_date": "2022-10-13", "last_synced_at": "2026-10-15T17:28:52.123Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02990078" }, { "nct_id": "NCT01382615", "title": "Protocol to Obtain Blood and Bone Marrow Samples for Myeloma Research", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Multiple Myeloma" ], "interventions": [], "intervention_types": [], "sponsor": "Dartmouth-Hitchcock Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 29, "start_date": "2010-08", "completion_date": "2014-12", "has_results": false, "last_update_posted_date": "2018-04-25", "last_synced_at": "2026-10-15T17:28:52.123Z", "location_count": 1, "location_summary": "Lebanon, New Hampshire", "locations": [ { "city": "Lebanon", "state": "New Hampshire" } ], "official_url": "https://clinicaltrials.gov/study/NCT01382615" }, { "nct_id": "NCT06326047", "title": "A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "NNC0519-0130", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Trizepatide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 299, "start_date": "2024-03-18", "completion_date": "2025-10-13", "has_results": false, "last_update_posted_date": "2026-09-21", "last_synced_at": "2026-10-15T17:28:52.123Z", "location_count": 55, "location_summary": "Chula Vista, California • Fresno, California • Inglewood, California + 46 more", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Inglewood", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Lancaster", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06326047" }, { "nct_id": "NCT02496728", "title": "NUYou:mHealth Intervention to Preserve and Promote Ideal Cardiovascular Health", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cardiovascular Disease" ], "interventions": [ { "name": "Mobile Health Application", "type": "BEHAVIORAL" }, { "name": "Environmental Cues", "type": "BEHAVIORAL" }, { "name": "Social Support", "type": "BEHAVIORAL" }, { "name": "Educational Materials", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "17 Years", "maximum_age": "26 Years", "sex": "ALL", "summary": "17 Years to 26 Years" }, "enrollment_count": 302, "start_date": "2015-05", "completion_date": "2019-02-28", "has_results": false, "last_update_posted_date": "2019-05-20", "last_synced_at": "2026-10-15T17:28:52.123Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02496728" }, { "nct_id": "NCT04431635", "title": "Dose De-escalation Study of the PI3k Alpha/Delta Inhibitor, Copanlisib Given in Combination With the Immunotherapeutic Agents, Nivolumab and Rituximab in Patients With Relapsed/Refractory Indolent Lymphoma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Indolent Lymphoma" ], "interventions": [ { "name": "Copanlisib", "type": "DRUG" }, { "name": "Nivolumab", "type": "DRUG" }, { "name": "Rituximab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Michigan Rogel Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 6, "start_date": "2020-06-15", "completion_date": "2023-11-14", "has_results": false, "last_update_posted_date": "2024-09-27", "last_synced_at": "2026-10-15T17:28:52.123Z", "location_count": 5, "location_summary": "Chicago, Illinois • Ann Arbor, Michigan • Omaha, Nebraska + 1 more", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Omaha", "state": "Nebraska" }, { "city": "New Brunswick", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT04431635" }, { "nct_id": "NCT06820515", "title": "ATHNdataset Registry", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hemophilia", "Thrombosis", "Hemophilia A", "Hemophilia B", "Sickle Cell Disease", "Glanzmann Thrombasthenia", "Bleeding Disorder", "Blood Disorder", "Von Willebrand Diseases" ], "interventions": [], "intervention_types": [], "sponsor": "American Thrombosis and Hemostasis Network", "sponsor_class": "NETWORK", "healthy_volunteers": null, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 200000, "start_date": "2024-10-25", "completion_date": "2055-10-31", "has_results": false, "last_update_posted_date": "2026-04-21", "last_synced_at": "2026-10-15T17:28:52.123Z", "location_count": 1, "location_summary": "Hickory, North Carolina", "locations": [ { "city": "Hickory", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06820515" }, { "nct_id": "NCT01970176", "title": "Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Systolic Cardiomyopathy (Aim2)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Cardiomyopathy", "Renal Impairment" ], "interventions": [ { "name": "Tadalafil", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "21 Years to 90 Years" }, "enrollment_count": 20, "start_date": "2014-01-09", "completion_date": "2019-09", "has_results": true, "last_update_posted_date": "2021-06-11", "last_synced_at": "2026-10-15T17:28:52.123Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01970176" }, { "nct_id": "NCT05659147", "title": "Imaging Biomarkers of Pancreatic Function and Disease", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pancreatitis", "Diabetes Mellitus" ], "interventions": [ { "name": "Research MRI without administration of intravenous secretin", "type": "DIAGNOSTIC_TEST" }, { "name": "Research MRI with administration of intravenous secretin", "type": "DIAGNOSTIC_TEST" }, { "name": "Genetic Sequencing", "type": "GENETIC" }, { "name": "Blood Tests", "type": "DIAGNOSTIC_TEST" }, { "name": "Stool Tests", "type": "DIAGNOSTIC_TEST" }, { "name": "Survey Completion", "type": "OTHER" }, { "name": "Endoscopic pancreatic function tests (ePFTs)", "type": "DIAGNOSTIC_TEST" }, { "name": "Secretin", "type": "DRUG" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "GENETIC", "OTHER", "DRUG" ], "sponsor": "Children's Hospital Medical Center, Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "5 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "5 Years to 21 Years" }, "enrollment_count": 195, "start_date": "2023-01-18", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-03-18", "last_synced_at": "2026-10-15T17:28:52.123Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05659147" }, { "nct_id": "NCT05421299", "title": "A Study to Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation Participants Treated With or Without Abatacept in Combination With a Calcineurin Inhibitor and Methotrexate", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Stem Cell Transplantation" ], "interventions": [], "intervention_types": [], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": null, "sex": "ALL", "summary": "6 Years and older" }, "enrollment_count": 378, "start_date": "2019-09-16", "completion_date": "2021-02-15", "has_results": false, "last_update_posted_date": "2022-06-16", "last_synced_at": "2026-10-15T17:28:52.123Z", "location_count": 1, "location_summary": "Princeton, New Jersey", "locations": [ { "city": "Princeton", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05421299" }, { "nct_id": "NCT00741416", "title": "Biorepository: Indiana Health Study", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Coronary Artery Disease", "Heart Disease", "Healthy" ], "interventions": [], "intervention_types": [], "sponsor": "Fairbanks Institute", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1400, "start_date": "2008-06", "completion_date": "2013-06", "has_results": false, "last_update_posted_date": "2011-07-01", "last_synced_at": "2026-10-15T17:28:52.123Z", "location_count": 14, "location_summary": "Avon, Indiana • Brownsburg, Indiana • Franklin, Indiana + 6 more", "locations": [ { "city": "Avon", "state": "Indiana" }, { "city": "Brownsburg", "state": "Indiana" }, { "city": "Franklin", "state": "Indiana" }, { "city": "Greenfield", "state": "Indiana" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00741416" } ] }